Home › IGA Glomerulonephritis › New York
IGA Glomerulonephritis clinical trials in New York
5 studies for IGA Glomerulonephritis are looking for participants at sites in New York.
Cities in New York
A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)
- Icahn School of Medicine at Mount Sinai, New York
- James J Peters Veterans Administration Medical Center - NAVREF - PPDS, The Bronx
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT06935357Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease
- ADARx Clinical Site, Great Neck
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 3, 2026 · NCT06989359Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
- NY Nephrology, Clifton Park
- Icahn School of Medicine at Mount Sinai, New York
RecruitingPhase 3
Ages 18 to 100 · All sexes · Updated Aug 17, 2026 · NCT06858319Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
- Cohen Children's Medical Center, New Hyde Park
RecruitingPhase 2
Ages 1 to 17 · All sexes · Updated May 12, 2026 · NCT05003986Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)
- The Rogosin Institute, New York
RecruitingObservational study
Ages 18 and older · All sexes · Updated Apr 4, 2025 · NCT01802034From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.